Metraipolis › archive › dc_7e0bf8b0c2bb

A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy — Europe PMC PMID:40906750

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40906750
DOI
10.1371/journal.pone.0328305
License (as archived)
solo-consultazione
Archived
2026-10-08T01:52:32.130Z
SHA-256 of the archived text
322db2809e741e35e73f8a29aff223502709c841f4e6cf948801920d8215f03b
Stable URL of this page
https://metraipolis.com/documento/dc_7e0bf8b0c2bb

How to cite

A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy — Europe PMC PMID:40906750 — Europe PMC (en), https://europepmc.org/article/MED/40906750 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e0bf8b0c2bb (Metraipolis archive dc_7e0bf8b0c2bb, sha256 322db2809e741e35e73f8a29aff223502709c841f4e6cf948801920d8215f03b)
BibTeX
@misc{dc7e0bf8b0c2bb,
  title = {A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy — Europe PMC PMID:40906750},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40906750},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e0bf8b0c2bb; sha256 322db2809e741e35e73f8a29aff223502709c841f4e6cf948801920d8215f03b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40906750. Agents can read the archived copy with the MCP tool read_document.